These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 38748928

  • 1. Medication adherence star ratings measures, health care resource utilization, and cost.
    Poonawalla IB, Chung L, Shetler S, Pearce H, Dixon SW, Racsa P.
    Am J Manag Care; 2024 May; 30(5):210-217. PubMed ID: 38748928
    [Abstract] [Full Text] [Related]

  • 2. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications.
    Axon DR, Vaffis S, Chinthammit C, Lott BE, Taylor AM, Pickering M, Black H, Warholak T, Campbell PJ.
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
    Leslie RS, Tirado B, Patel BV, Rein PJ.
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1193-203. PubMed ID: 25443513
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hypertension, cholesterol and diabetes medication adherence, health care utilization and expenditure in a Medicare Supplemental sample.
    Campbell PJ, Axon DR, Taylor AM, Smith K, Pickering M, Black H, Warholak T, Chinthammit C.
    Medicine (Baltimore); 2021 Sep 03; 100(35):e27143. PubMed ID: 34477169
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study.
    Chinthammit C, Axon DR, Mollon L, Taylor AM, Pickering M, Black H, Warholak T, Campbell PJ.
    J Manag Care Spec Pharm; 2021 Jan 03; 27(1):64-72. PubMed ID: 33377445
    [Abstract] [Full Text] [Related]

  • 10. Impact of a value-based formulary in three chronic disease cohorts.
    Yeung K, Basu A, Marcum ZA, Watkins JB, Sullivan SD.
    Am J Manag Care; 2017 Mar 03; 23(3 Suppl):S46-S53. PubMed ID: 29648740
    [Abstract] [Full Text] [Related]

  • 11. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.
    Mhatre SK, Serna O, Sansgiry S, Fleming ML, Essien EJ, Sansgiry SS.
    J Manag Care Spec Pharm; 2016 Nov 03; 22(11):1293-1301. PubMed ID: 27783546
    [Abstract] [Full Text] [Related]

  • 12. Racial/ethnic disparities in measure calculations for Part D Star Ratings among Medicare beneficiaries with diabetes, hypertension, and/or hyperlipidemia.
    Steve Tsang CC, Wan JY, Chisholm-Burns MA, Li M, Dagogo-Jack S, Cushman WC, Hines LE, Wang J.
    Res Social Adm Pharm; 2021 Aug 03; 17(8):1469-1477. PubMed ID: 33272859
    [Abstract] [Full Text] [Related]

  • 13. Association of Medication Adherence with Hospital Utilization and Costs Among Elderly with Diabetes Enrolled in a State Pharmaceutical Assistance Program.
    Pednekar P, Heller DA, Peterson AM.
    J Manag Care Spec Pharm; 2020 Sep 03; 26(9):1099-1108. PubMed ID: 32857648
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Medication Adherence to Antihypertensive Triple-Combination Therapy Among Patients Enrolled in a Medicare Advantage Plan.
    Wang X, Chen H, Essien E, Wu J, Serna O, Paranjpe R, Abughosh S.
    J Manag Care Spec Pharm; 2019 Jun 03; 25(6):678-686. PubMed ID: 31134857
    [Abstract] [Full Text] [Related]

  • 18. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes.
    Wu J, Seiber E, Lacombe VA, Nahata MC, Balkrishnan R.
    Ann Pharmacother; 2011 Mar 03; 45(3):342-9. PubMed ID: 21325098
    [Abstract] [Full Text] [Related]

  • 19. Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial.
    Choudhry NK, Isaac T, Lauffenburger JC, Gopalakrishnan C, Lee M, Vachon A, Iliadis TL, Hollands W, Elman S, Kraft JM, Naseem S, Doheny S, Lee J, Barberio J, Patel L, Khan NF, Gagne JJ, Jackevicius CA, Fischer MA, Solomon DH, Sequist TD.
    JAMA Intern Med; 2018 Sep 01; 178(9):1182-1189. PubMed ID: 30083727
    [Abstract] [Full Text] [Related]

  • 20. A Pharmacist-Led, Patient-Centered Program Incorporating Motivational Interviewing for Behavior Change to Improve Adherence Rates and Star Ratings in a Medicare Plan.
    Spears J, Erkens J, Misquitta C, Cutler T, Stebbins M.
    J Manag Care Spec Pharm; 2020 Jan 01; 26(1):35-41. PubMed ID: 31880222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.